The most expensive regulatory mistakes are not made at launch. They are made months or years earlier, when a product team is locked in a classification, makes a claims decision, or chooses a supplier without understanding the U.S. regulatory implications of any of those choices. By the time the error surfaces, the available options are limited, and the costs are high. Arantxa Jordán, an international trade and regulatory advisor, works with companies entering the U.S. market on the discipline that prevents exactly that sequence. “Regulation should enter the conversation at the concept stage,” Jordán states, “not at the pre-launch checklist stage, which is the most common thing that happens.”
Regulatory Built-In Moves Faster Than Regulatory Bolted-On
The instinct that treating regulation as a late-stage concern saves time is one of the most consistently disproven assumptions in product development. It may feel slower in the first week, as harder questions are asked earlier. Over the life of the product, it removes months of friction. Most delays do not come from regulators. They come from companies discovering too late that they chose the wrong pathway, the wrong classification, or the wrong claims.
Teams that move fast without a regulatory foundation pay for that speed with recalls, blocked shipments, and emergency legal costs. “That kind of speed is deceptive,” Jordán reflects, “because it looks good on a launch announcement, but it quietly destroys return on investment (ROI).” When regulation is built in from the concept stage, development, supply chain, quality, and marketing align around a realistic path. Approvals and registrations are queued properly. Documentation is generated progressively. Origin and supplier information is captured correctly from the start rather than reconstructed under pressure before a shipment date. The stop-and-go pattern that consumes launch timelines disappears.
U.S. Classifications Do Not Follow International Logic
One of the most consequential gaps for companies entering the U.S. market is the assumption that product classifications from their home market will translate. They frequently do not, and the difference determines the entire regulatory pathway, cost structure, and timeline required to bring a product to market. Cavity-preventing toothpaste is a cosmetic in Europe. In the U.S., it is a drug. Skincare products with certain claims are cosmetics in many markets and fall under drug regulation in the U.S. due to the nature of those claims. These are not edge cases; they are the kind of classification mismatches that companies encounter regularly when they attempt to apply international regulatory logic to the U.S. market. “If the first time U.S. regulation appears on the slide deck is after the design freeze,” Jordán warns, “the company is already accepting unnecessary risk.” The concept stage is precisely when those classification decisions can still be influenced, before the product design, the claims, and the supplier relationships are locked in around the wrong framework.
Prepare for the USMCA Review Before It Forces Your Hand
With the United States–Mexico–Canada Agreement (USMCA) review expected this summer, Jordán’s guidance to senior leaders is to treat it as a stress test for the current operating model rather than an event to predict or lobby around. The companies that will navigate it best are not the ones with the most political access; they are the ones that enter the review period with clean data, flexible sourcing structures, and clear internal processes for translating legal changes into operational decisions.
Three capabilities matter most:
- Visibility: into product-by-product value creation; how close the organization is to current rules-of-origin thresholds, and how a change would cascade through costs and pricing.
- Optionality: having alternative sourcing and routing options identified, even if not yet activated.
- Governance: ensuring someone at the executive level is accountable for monitoring the review, scenario planning, and making concrete operational decisions as the landscape shifts.
“Leaders should put that architecture in place now,” Jordán states, “before headlines force them into reactive decision-making.” Regulatory knowledge is one of the foundational elements of any business plan. Most of the reasons products fail in the U.S. market trace back to regulatory issues that were knowable and avoidable, long before the product ever shipped.
About Yellowstone Consulting Group
Yellowstone Consulting Group helps international companies translate their global ambitions into tangible, structured results in the U.S. market. With over a decade of experience, the firm partners with businesses to design tailored solutions from regulatory compliance and company formation to business development and market positioning, turning ambition into achievement. Trusted by international companies across Europe, Latin America, and Asia, Yellowstone Consulting Group brings together strategic insight and cultural understanding to ensure each project grows with purpose, precision, and sustainability. A boutique consulting firm transforming complexity into clarity and growth in the U.S. market.
Follow Arantxa Jordán on LinkedIn for more insights on regulatory strategy, U.S. market entry, and building the compliance foundations that accelerate rather than constrain commercial growth.
